The College would like to thank pharmacists and pharmacy technicians in the Fraser Valley (District 2), Kootenay/Okanagan (District 4), Urban Hospitals (District 6), and Pharmacy Technicians (District 8) that voted in the 2018 Board elections.
In June 2018, the College Board approved housekeeping amendments to the Drug Schedules Regulation (DSR) under the Pharmacy Operations and Drug Scheduling Act (PODSA) to improve its alignment with the National Drug Schedules developed by the National Association of Pharmacy Regulatory Authorities (NAPRA...
The highlights from the September Board Meeting are now available.
Highlights from this meeting include new requirements for electronic record keeping; BC's approach to cannabis legalization and regulation; updates on our commitment to cultural safety and humility; and a new Patient Relations Program Standard.
Vancouver, BC – Results of an investigation into the now closed Marigold Compounding and Natural Pharmacy in Courtney, BC showed a blatant disregard for public safety and meeting pharmacy practice standards by pharmacy manager Isidoro Andres “Rudy” Sanchez.
Polls are now open for Fraser Valley (District 2), Kootenay/Okanagan (District 4), Urban...
On September 1, 2018, the new Professional Practice Policy-67 for Injectable Opioid Agonist Treatment (iOAT), as well as an accompanying Policy Guide for Injectable Hydromorphone Maintenance Treatment will come into effect. These documents set out the requirements for the safe dispensing of injectable hydromorphone for the treatment of opioid use disorder...
Registrants can now submit declarations of completion on eServices upon their successful completion of certain knowledge and training requirements in the College’s bylaws and Professional Practice Policies
Professional Practice Policy-69: Community Pharmacy Manager Education (PPP-69), which provides guidance to community pharmacy managers on complying with their obligations under the Pharmacy Operations and Drug Scheduling Act (“PODSA”) and PODSA bylaws, will be in effect as of September 1, 2018.
Following previous shortage announcements in 2018, Health Canada and Pfizer Canada have announced that the shortage of EpiPen...
August 18, 2018 - Further to the initial recall of certain valsartan products because of the presence of NDMA in the active ingredient, Health Canada is now advising Canadians that, as a precautionary measure, Teva Canada is expanding its voluntary recall to include eight...